01 4GLAXO GRP LTD
02 2MYLAN SPECIALITY LP
03 14PARATEK PHARMS
04 154TEVA PHARM
01 1410195375*PED
02 710918816*PED
03 711173259*PED
04 711344685*PED
05 1411969544*PED
06 27500444
07 27500444*PED
08 17975690
09 18168620
10 18168620*PED
11 18550073
12 18978647
13 69066957
14 29415008
15 149616024
16 69987229
17 110076614
18 110076615
19 110124132
20 110179216
21 1410195375
22 110252010
23 110300229
24 110478574
25 710918816
26 111033696
27 711173259
28 711344685
29 111554229
30 111602603
31 1411969544
32 112083270
33 69066957*PED
34 29415008*PED
35 149616024*PED
36 69987229*PED
01 174Blank
01 89Y
02 85Blank
01 202024-09-01
02 202025-03-01
03 12025-12-29
04 12026-02-24
05 22026-02-26
06 12026-08-24
07 22026-08-26
08 12027-03-06
09 12028-10-27
10 12029-07-30
11 12029-10-22
12 12030-12-06
13 12031-02-07
14 142031-02-14
15 12031-04-04
16 142031-08-14
17 12033-05-20
18 12033-07-08
19 12033-11-04
20 82034-10-06
21 12034-10-20
22 82035-04-06
23 12035-07-07
24 72035-12-14
25 12036-02-23
26 72036-06-14
27 142039-08-20
28 72039-09-26
29 142040-02-20
30 72040-03-26
31 72040-07-06
32 72041-01-06
Patent Expiration Date : 2026-02-26
US Patent Number : 7500444
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21433
Patent Use Code :
Delist Requested : Y
Patent Use Description :
Patent Expiration Date : 2026-02-26
Patent Expiration Date : 2026-02-26
US Patent Number : 7500444
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21433
Patent Use Code :
Delist Requested : Y
Patent Use Description :
Patent Expiration Date : 2026-02-26
Patent Expiration Date : 2026-08-26
US Patent Number : 7500444*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 21433
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-08-26
Patent Expiration Date : 2026-08-26
US Patent Number : 7500444*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 21433
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-08-26
Patent Expiration Date : 2034-10-06
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US Patent Number : 9066957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208799
Patent Use Code : U-645
Delist Requested :
Patent Use Description : TREATMENT OF ASTHMA
Patent Expiration Date : 2034-10-06
Patent Expiration Date : 2034-10-06
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US Patent Number : 9415008
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208799
Patent Use Code : U-645
Delist Requested :
Patent Use Description : TREATMENT OF ASTHMA
Patent Expiration Date : 2034-10-06
Patent Expiration Date : 2034-10-06
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US Patent Number : 9066957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208799
Patent Use Code : U-645
Delist Requested :
Patent Use Description : TREATMENT OF ASTHMA
Patent Expiration Date : 2034-10-06
Patent Expiration Date : 2034-10-06
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US Patent Number : 9066957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208799
Patent Use Code : U-645
Delist Requested :
Patent Use Description : TREATMENT OF ASTHMA
Patent Expiration Date : 2034-10-06
Patent Expiration Date : 2034-10-06
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US Patent Number : 9066957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208799
Patent Use Code : U-645
Delist Requested :
Patent Use Description : TREATMENT OF ASTHMA
Patent Expiration Date : 2034-10-06
Patent Expiration Date : 2034-10-06
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US Patent Number : 9415008
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208799
Patent Use Code : U-645
Delist Requested :
Patent Use Description : TREATMENT OF ASTHMA
Patent Expiration Date : 2034-10-06
